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Abstract
Background: Missing data in covariates can result in biased estimates and loss of power to detect associations. It
can also lead to other challenges in time-to-event analyses including the handling of time-varying effects of
covariates, selection of covariates and their flexible modelling. This review aims to describe how researchers approach
time-to-event analyses with missing data.
Methods: Medline and Embase were searched for observational time-to-event studies in oncology published from
January 2012 to January 2018. The review focused on proportional hazards models or extended Cox models. We
investigated the extent and reporting of missing data and how it was addressed in the analysis. Covariate modelling
and selection, and assessment of the proportional hazards assumption were also investigated, alongside the
treatment of missing data in these procedures.
Results: 148 studies were included. The mean proportion of individuals with missingness in any covariate was 32%.
53% of studies used complete-case analysis, and 22% used multiple imputation. In total, 14% of studies stated an
assumption concerning missing data and only 34% stated missingness as a limitation. The proportional hazards
assumption was checked in 28% of studies, of which, 17% did not state the assessment method. 58% of 144
multivariable models stated their covariate selection procedure with use of a pre-selected set of covariates being the
most popular followed by stepwise methods and univariable analyses. Of 69 studies that included continuous
covariates, 81% did not assess the appropriateness of the functional form.
Conclusion: While guidelines for handling missing data in epidemiological studies are in place, this review indicates
that few report implementing recommendations in practice. Although missing data are present in many studies, we
found that few state clearly how they handled it or the assumptions they have made. Easy-to-implement but
potentially biased approaches such as complete-case analysis are most commonly used despite these relying on
strong assumptions and where often more appropriate methods should be employed. Authors should be
encouraged to follow existing guidelines to address missing data, and increased levels of expectation from journals
and editors could be used to improve practice.
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Background
Time-to-event or survival studies focus on the analysis of
times to an outcome or event. Missing data in covariates
is a problem in many such investigations. It can render
estimators biased if applied to the complete-cases or using
an ad hoc approach to handling missingness, and a loss
of power to detect associations between explanatory vari-
ables and times-to-event. The presence of missing data
can also lead to further challenges in a survival setting
such as the handling of time-varying effects or dealing
with time-dependent covariates when values are missing
in the covariates in question. Additionally, it can lead to
questions about how best to approach the checking of
model assumptions, for example, the proportional haz-
ards assumption when using a Cox model. Missing data
also brings further challenges not specific to time-to-
event scenarios, such as how to address the selection of
covariates into a model or the flexible modelling of covari-
ates. Another type of missingness concerning time-to-
event scenarios is missing observations of the event time
due to patients being censored, for example, due to admin-
istrative censoring or loss to follow-up. This is typically
addressed in the analyses for right-censored data, mak-
ing the assumption that the censoring is uninformative.
Missingness in the outcome is not assessed in this review
which instead focuses on missing data in the explanatory
covariates only.
Complete-case analysis is both a simple and popular
method for dealing with missing data, which involves
restricting the analysis to individuals with nomissing data.
Other simple approaches involve replacing missing obser-
vations in a covariate with the mean, median or modal
value or the use of a missing indicator category for cate-
gorical covariates. While popular, these methods can be
biased, inefficient or underestimate the variance of esti-
mates. Multiple imputation is an increasingly popular
method for handling missing data which involves repli-
cating the original dataset multiple times and in each
replication replacing the missing values with plausible
observations drawn from the posterior predictive distri-
bution [1]. It is typically conducted using the ‘missing
at random’ (MAR) assumption [2], which also subsumes
‘missing completely at random’ (MCAR). MCAR means
that missingness does not depend on the observed or
missing values while MARmeans that missingness is con-
ditionally independent of the missing values given those
which have been observed. Further methodology has been
developed to adapt the use of multiple imputation in a
survival setting. White and Royston in 2009 [3] focused
on the Cox model and recommend including the Nelson-
Aalen estimate and event indicator in the imputation
model. Bartlett et al in 2015 [4] described an alternative
imputation approach suitable for several analysis models
including the Cox model and Keogh andMorris (2018) [5]
adapted both approaches to handle time-varying covariate
effects - that is, non-proportionality of hazards.
In addition to developed methodology, there have been
several published guidelines focusing on how to conduct
and report an observational study with some recommen-
dations pertinent to reporting with incomplete covariate
data, summarised in Table 1. Some guidelines, such as
Sterne et al. [6] focus purely on the handling and reporting
of missing data while using multiple imputation, whereas
STROBE [7, 8] and ROBINS-I [9] focus more generally
on reporting of observational studies. Examples of rec-
ommendations range from providing detail on eligibility
criteria of patients to clearly stating the selection pro-
cess for the final analysis model to reporting the amount
of missingness in each covariate and which method was
chosen to deal with the missing observations. Sensitivity
analyses are also recommended to investigate plausibility
of any assumptions assumed and the robustness of results.
These published guidelines aim to introduce transparency
as well as replicability of results if another analyst were to
conduct the same investigation.
Time-to-event studies are commonly conducted in
oncology with a search for time-to-event or survival stud-
ies on Web of Science indicating oncology to be the most
popular category at approximately 30% of journal arti-
cles. As such, this review focused on studies conducted in
any area of oncology. Common scenarios involve assess-
ing the risk factors of patients developing a specific cancer
or investigating factors associated with survival post-
diagnosis. Proportional hazards models and Cox regres-
sion, in particular, continues to be the dominant analysis
technique in time-to-event studies. As such, the review
focuses on proportional hazardsmodels while allowing for
the extension of the Cox model to include time-varying
effects.
Given the developed methodology in this field and the
detailed recommendations in place, this review aims to:
• understand which methods researchers are using in
time-to-event analyses when missing data are present
• assess if methods used are being carried out
appropriately and the relevant assumptions stated
• assess how other challenges such as covariate
selection, choice of functional forms (i.e. whether the
covariate should be included as a linear term or be
more flexibly modelled) for continuous covariates
and checking of model assumptions are handled,
particularly in the presence of missing data.
Methods
Databases, search strategy and screening
Medline and Embase databases were searched for
studies published between January 2012 and January 2018
to allow time for developed methods and guidelines to
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Table 1 Summary of recommendations or considerations from STROBE, ROBINS-I and Sterne et al. guidelines
Recommendation Explanation STROBE ROBINS-I Sterne et al.
Patient Selection
State eligibility criteria State inclusion and exclusion criteria of study
participants, including criteria concerning missing
data
 
Report the number of individuals at
each stage of the study
Give reasons for exclusion at each stage 
Indicate the amount of individuals discarded due to
missingness at each stage of the study
 
Give consideration to selection bias introduced by
exclusion criteria

May use a flowchart to summarise 
Modelling and Covariate Selection
Covariates Detail whether included as continuous or categorical
and, if relevant, detail how the quantitative covariate
was categorised
 
Consider departures from linearity for continuous
covariates and state which transformation, if any, was
used
 
State analysis model make it clear which method will be used to model
the data
 
Covariate Selection describe the procedure used to reach the final model  
this includes, but is not restricted to, missing data
imputation, transformation of covariates, interactions
between covariates or inclusion of covariates for a
priori reasons
 
Results Provide unadjusted estimates and the final adjusted
model
 
State the number of participants included in
unadjusted and adjusted analyses

Missing Data
Report the number of participants
with missing data
Report this for each covariate of interest or the
number of complete data for the important
covariates
 
Give reasons for missing values   
Investigate if there are key differences between those
observed and those with missing data - this may be
compared across exposure/intervention groups.
 
Missing datamethods (general)
Which method was used to handle
missing data?
State clearly the method used   
State any missing data assumptions
that were made
Such as whether the data are MCAR, MAR or MNAR   
Sensitivity analysis Should investigate robustness of findings  
Compare method with a complete-case analysis 
If necessary, assess validity of methods if there are
differences
 
Assess plausibility of missing data assumptions 
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Table 1 Summary of recommendations or considerations from STROBE, ROBINS-I and Sterne et al. guidelines (Continued)
Recommendation Explanation STROBE ROBINS-I Sterne et al.
Multiple Imputation
Give details of the imputation
model
State the software used and key settings for imputation model 
State the number of imputations used 
State variables included in imputation model 
State how non-normal or binary covariates were handled 
Were interactions in analysis model included in imputation
model?

If a large fraction of data are
imputed, compare observed and
imputed values

Missing data assumptions Discuss if variables included in the imputation model make
MAR assumption plausible

Sensitivity analyses Compare MI results with CC results 
Investigate departures from MAR assumption 
If necessary, suggest explanations for why there are differences
in results across sensitivity analyses

be used in practice. The search strategy for observa-
tional studies consisted of three main components: oncol-
ogy, missing data and time-to-event analyses; additional
details can be found in Additional file 1.
For inclusion, studies had to use a proportional haz-
ards or an extended Cox model (includes an interaction
between a covariate and time) in a cancer setting. The
study also had to have a reference to missing data (either
‘complete’ or ‘missing’) in the abstract or in the full-text.
Studies involving only competing risks, frailty models,
accelerated failure time models or excess hazards in the
abstract or full-text were excluded from the review. If the
abstract mentioned a time-to-event outcome but did not
specify the analysis models used, the paper proceeded to
a full-text review. Papers not written in English or which
focused on methodology, meta-analyses, validations of
previously created models, and primary or secondary trial
outcomes were excluded. However, retrospective observa-
tional analyses of a trial cohort were included.
Data extraction
The information extracted focused on two key areas:
missing data and features of the time-to-event analysis.
The missing data component assessed the sample size
used in the study, how much missing data had been dis-
carded, if assumptions about the treatment of missing
data in the analysis were stated and how any missing
data were handled in the analysis: complete-case anal-
ysis, single imputation techniques or multiple imputa-
tion. Where multiple imputation was used, the choice of
univariate or multivariate imputation was recorded, the
number of imputations used and which covariates were
included in the imputation model. Online supplementary
materials were accessed only when referenced with
regards to the handling ofmissing data in the text. The fea-
tures of the time-to-event analysis assessed were whether
the proportional hazards assumption was investigated,
how covariates were selected for model inclusion and the
assessment of the functional form (if continuous covari-
ates were included). We also assessed, where relevant,
how missing data were treated in the context of these fea-
tures. In addition, the software used for the analysis was
also extracted by searching for ‘Stata’, ‘SAS’, ‘SPSS’, ‘R’ and
‘plus’ (for S-plus and Mplus). Papers which did not men-
tion one of these six programs were then searched for the
software used. A detailed list of the information extracted
can be found in Additional file 1 which was motivated by
the guideline recommendations found in Table 1 and are
evaluated in the “Results” section.
A pilot investigation consisting of 10 randomly selected
papers was carried out by OUC, TPM and RHK to assess
the consistency of data extraction, refine the data extrac-
tion checklist and agree on how to extract information
when answers were ambiguous. Data extraction was then
carried out by OUC.
Results
The PRISM diagram [10] summarising the review inclu-
sion process is shown in Fig. 1. Four hundred and eigh-
teen papers were identified from Embase and Medline,
of which 309 were non-duplicates and proceeded to the
screening step. One hundred and thirty-seven studies
did not meet the inclusion criteria during screening and
were therefore excluded. After a full-text assessment, a
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Fig. 1 Flowchart of the inclusion process for studies into the review [10]
further 24 studies were excluded with a total of 148
studies included within the review. The studies included
came from 110 journals, of which the most prominent
were BMC Cancer (5), International Journal of Radiation
Oncology, Biology, Physics (4) and Journal of the National
Cancer Institute (4).
Missing data
Reporting extent of missing data
In the pilot stage we noticed that many studies excluded
individuals due to missing data on key covariates in an ini-
tial phase (in which the study population was determined
using inclusion or exclusion criteria). That is, having cer-
tain covariates observed was used as part of the inclusion
criteria. One hundred and six (72%) studies excluded
missing data while determining their study population
in this initial phase. Of the 106 studies which excluded
observations, 66 (62%) reported the number of individ-
uals excluded. On average, 14% of individuals were dis-
carded during this stage. After inclusion criteria had been
applied, 102 (69%) studies contained patients with missing
data. Table 2 shows the breakdown of missing data during
the initial phase and analysis stage of the study.
In the demographics table (often considered to be ‘Table
1’ in publications), 87 (59%) studies summarised the miss-
ing data in covariates, 47 (32%) reported the breakdown of
missingness in incomplete covariates and two (1%) used
missing data pattern plots. Thirty-four (23%) used both
the text and a table to report the extent of missingness.
For the 48 (32%) who did not use a plot, use a table or
explicitly break down the missing values in each covari-
ate a general statement was typically made stating which
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Table 2 Breakdown of the number of individuals with missing
data
Description Number (%)
Excludedmissing data in initial
phase (N=106)
Excluded individuals with missing
data in any covariate1
44 (42)
Excluded individuals with missing
data in a subset of covariates
62 (58)
Reported the number of individuals
excluded
66 (62)
Percentage (%) of individuals
excluded (n = 66)
Mean (SD) 14.14 (12.40)
Median (IQR) 10.22 (4.73, 18.34)
Min, Max 0.11 47.38
Missing data present for the
analysis stage (N=102)
Reported missing data in baseline
table for incomplete covariates
82 (80)
Used a complete-case analysis2 35 (34)




Percentage (%) of individuals
excluded (n = 25)
Mean (SD) 31.65 (21.90)
Median (IQR) 31.34 (13.67, 37.76)
Min, Max 1.77 94.16
The initial phase is the stage when defining the study population using inclusion
and exclusion criteria.
1potentially used a complete-case in initial phase but did not clearly state their
methods
2A further 31 were not clear on whether they used a complete-case during the
analysis
variables were incomplete or that variables or patients
were excluded due to having incomplete data.
Analyses performed
Table 3 summarises the methods used for the analysis in
the presence of missing data. Complete-case analysis was
the most popular and was used in 79 (53%) studies either
in the initial phase or at the analysis stage (either as the
primary method used to deal with missing data or as a
sensitivity analysis). This was followed in popularity by
removing individuals with missing values in certain key
covariates (62, 42%) and multiple imputation (33, 22%).
Some studies used multiple methods for handling missing
data with 18 (12%) using both complete-case and multiple
imputation.
68 (50%) of all studies used a complete-case analysis as
their primary analysis method and 24 (16%) reportedmul-
tiple imputation as their main analysis. Of those using
Table 3 Methods used in studies for the handling of missing data
Missing data methods Count (%)*
Complete-case 79 (53)
Removed individuals with
incomplete data for a subset of
covariates
67 (45)
Multiple Imputation 33 (22)
Missing indicator 10 (7)
Worst or best case scenario1 2 (1)
Stochastic imputation 1 (1)
Mean value imputation 1 (1)
Mode value imputation 1 (1)
Growth models 1 (1)
Bayesian model incorporating





Selection procedure3 1 (1)
Unclear 33 (22)




3A selection model to account for missing data and time-varying covariates [13]
complete-case analysis as the main analysis, nine (13%)
also used MI or other methods. Of those using MI as the
main analysis, 12 (50%) used complete-case analysis or
another method as a secondary analysis.
Missing data assumptions
Of the 148 studies, 128 (86%) did not state the assump-
tions that their chosen analysis made regarding the miss-
ing data. Eighteen (12%) stated the MAR assumption, of
which 16 (89%) gave a general statement such as ‘MAR
was assumed’, with no further explanation. One (0.7%)
study stated MCAR and another stated ‘missing not at
random’.
Sensitivity analyses and statingmissing data as a limitation
Ninety-eight (66%) studies did not mention the presence
of missing data as a limitation to their analysis. Twenty-
six (18%) used sensitivity analyses to check the robustness
of their final results to either different assumptions con-
cerning the missingness or comparing results with other
techniques to handle missing data.
Description of complete-case analysis
Thirty-five (34%) used a complete-case analysis and a fur-
ther 31 (30%) were suspected to have used complete-case
during the analysis stage based on the information pro-
vided but did not state this clearly in their paper. On
average, 32% of individuals were discarded by applying a
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complete-case analysis, the maximum being 94% where
complete-case was used as a sensitivity analysis for com-
parison with the main analysis using multiple imputation.
Figure 2 summarises the reporting of missing data in the
79 studies that used a complete-case analysis (either dur-
ing the initial phase or analysis stage). Seven (16%) of
the 44 (56%) studies using the initial phase complete-case
stated missing data as a limitation. Of the two (5%) studies
using a sensitivity analysis, one compared with multiple
imputation and the other compared the initial complete-
case results pre and post propensity score matching and
therefore with different sample sizes. Thirty-five (44%)
studies used complete-case during the analysis stage, of
which 18 (51%) statedmissing data as a limitation. In addi-
tion, we presumed based on the information provided that
a further 33 studies used a complete-case in the initial
phase or analysis stage but did not clearly state this as their
method to handle missing data.
Sensitivity analyses with complete-case: Eighteen
(51%) studies used a sensitivity analysis, of which 14
(78%) involved multiple imputation versus complete-case
analysis, two (11%) used complete-case analysis where
individuals with missing data in any covariate were
excluded versus excluded if there were missing data in a
specific subset of covariates (known as available case anal-
ysis), one (6%) tested various missing data assumptions
and one (6%) did not specify.
Description ofmultiple imputation
The breakdown of multiple imputation usage can be
seen in Fig. 3. Thirty-three (22%) studies used multi-
ple imputation, of which 24 (73%) reported the multiple
imputation estimates as their main study results. Four-
teen (42%) stated a missing data assumption and 25 (76%)
described whether a multivariate or univariate approach
was taken. For those using a multivariate imputation
approach (22, 88%), multivariate imputation by chained
equations (MICE) was the most popular method (19,
86%). In total, 14 (42%) studies included a component
of the time-to-event outcome in their imputation model.
These included the baseline hazard (7, 50%), the event
indicator (9, 14%) or both (2, 14%). Twenty-six (79%)
studies using multiple imputation stated the number of
imputations. One (3%) used a single imputation, five (15%)
Fig. 2 Breakdown of complete-case (CC) usage. The initial phase refers to those who used complete-case analysis when determining
inclusion/exclusion of individuals to the study population
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Fig. 3 Breakdown of multiple imputation (MI) usage. 1 2 did not specify the type of multivariate MI model used, similarly 1 for univariate. 2 1 study
ensured the sample size stayed the same for different models. 3 3 studies did not clearly state that they were using complete-case
used five, six (18%) used 10, seven (21%) used 20, two
(6%) used 25 and five (15%) used 50. Some studies (exam-
ple: [14]) cited the White, Royston and Wood paper [15]
which suggests that the rule of thumb for choosing the
number of imputations should be at a minimum the per-
centage of cases that are incomplete while other studies
(example: [16]) stated the number of imputations with no
justification.
Sensitivity analyses with multiple imputation: Of the
21 (64%) studies that conducted a sensitivity analysis, 18
(90%) compared complete-case and multiple imputation
(three of which did not explicitly state complete-case) and
10 (56%) used multiple imputation as the main analysis
method and one (6%) was unclear on the main strategy
while reporting both multiple imputation and complete-
case results.
Missing data assumptions withmethods
Of the 18 studies which stated the MAR assumption,
11 (61%) used multiple imputation, two (11%) used
complete-case and one (16%) was not clear on whether
they used complete-case or multiple imputation, two
(11%) were suspected to have used complete-case but did
not clearly state, one (16%) used a stochastic single regres-
sion imputationmodel and one (16%) used a fully Bayesian
model. The one study stating MCAR used complete-case
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analysis and the other stating ‘missing not at random’ per-
formed an analysis using a selection model for the joint
distribution of the missing covariates, the outcome and
the probability that covariate data are missing [13].
None of the 44 (56%) studies using the initial phase
complete-case stated a missing data assumption and for
the 35 using complete-case analysis during the analysis
stage 10 (29%) stated amissing data assumption. This con-
sists of one (10%) study stating MCAR and nine (90%)
MAR, of which seven (78%) used multiple imputation
and complete-case analysis together for sensitivity anal-
yses (six (86%) of these used multiple imputation as the
main method for handling missing data and complete-
case analysis used as a comparison). For the 14 studies
using multiple imputation having stated a missing data
assumption, 13 (93%) used MAR and one (7%) used
MCAR.
Features of the analysis
Selection of covariates into themodel
One hundred and forty-four (97%) studies used a multi-
variable model and therefore used some selection method
or criteria to select which covariates should be included.
Of these, 85 (59%) stated a clear selection procedure. The
use of a predefined set of covariates (33, 39%), stepwise
methods (31, 37%) and univariable analyses (32, 38%) were
most commonly used, with eight (10%) studies using both
a predefined set and univariable analyses. Of the 31 stud-
ies using stepwise methods, backwards elimination was
used in 18 (58%), six (19%) used forwards selection and
seven (23%) did not state which type of stepwise method
was used.
Eleven (35%) used complete-case as the main method to
handle missing data. Five (45%) out of the 31 studies using
stepwise methods stated excluding individuals with miss-
ing data on key covariates in the initial phase, and were left
with no additional missing data at the analysis phase. Six
(55%) studies that used a stepwise procedure did so in a
complete-case analysis. We suspect that an additional six
(19%) studies used complete-case analysis but this was not
clearly stated.
For the 31 studies using stepwise methods, 10 (32%)
used them in combination with multiple imputation. Of
this, eight (80%) used multiple imputation as the main
method to handle missing data, one (10%) used a missing
indicator as the main method with multiple imputation
as a sensitivity analysis and one (10%) used a sensitiv-
ity analysis but did not state whether multiple imputation
or complete-case was the main method. For those who
used multiple imputation as the primary method to han-
dle missing data, seven (88%) did not state how they
combined it with the stepwise methods and the other is
suspected to have applied the stepwise procedure in a
complete-case analysis to determine the set of covariates
to be included, before using this set in the model fitted in
each imputed dataset, however this was not clearly stated.
For the 32 studies using univariable analyses, four (13%)
studies used multiple imputation as the main analysis
method, 14 (44%) stated that they used a complete-case as
the main method for handling missing data, 12 (38%) were
presumed to have used a complete-case analysis based on
the information available, one (3%) used stochastic single
regression imputation model and one (3%) did not include
incomplete covariates in the analysis model (available case
analysis).
Functional form of continuous covariates
Sixty-nine (47%) studies included continuous covariates in
their model, of which 57 (83%) did not report consider-
ing whether any form other than linear was required, i.e.
its appropriate functional form. For those that did con-
sider it, splines were themost popular way of transforming
covariates in the model (8, 12%), followed by fractional
polynomials (2, 3%) and Martingale residuals (2, 3%).
Including a quadratic term or a ‘flexible non-linear model’
were each used once. One study used Martingale residu-
als, cubic splines and fractional polynomials to investigate
evidence of non-linear associations [17]. For a further 11
(7%) studies, it was not clear whether included covari-
ates were continuous or categorical. For the 12 studies
which reported assessing the functional form of covari-
ates, three (25%) used multiple imputation as the main
method for handling missing data, three (25%) used ini-
tial phase complete-case, three (25%) presumably used
complete-case analysis but this was not clearly stated, one
(8%) used stochastic single regression imputation, one
(8%) used a study-specific model to impute missing val-
ues and one (8%) used available case analysis by restricting
to individuals with complete data in the covariates to be
included in the analysis model.
Proportional hazards assumption and time-varying effects of
covariates
The primary analysis method in 142 (96%) studies was
the Cox model and the remaining six (4%) stated the use
of a proportional hazards model. When investigating the
proportional hazards assumption, the covariates included
within the analysis model should be assessed. Forty-
one (28%) studies stated that the proportional hazards
assumption was assessed either using a general statement
(example:[18]) or specifically detailing how to handle the
covariates which violated it (example:[19]). Of those who
checked, seven (17%) did not state the method used to
assess the assumption. Schoenfeld residuals were most
frequently used (18, 44%), followed by visual inspection
of plots of Kaplan-Meier estimates of survivor curves, or
functions thereof (12, 29%). Of these two methods, seven
(17%) studies used both. Ten (24%) studies tested the
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assumption by including an interaction between covari-
ates and follow-up time in the model.
For the studies that checked the assumption, 13 (32%)
used multiple imputation as the main method to han-
dle missing data, three (7%) used a missing indicator,
11 (27%) used complete-case analysis, seven (17%) pre-
sumably used complete-case analysis but did not clearly
state, two (5%) had no missing data in covariates chosen
for inclusion in the analysis model, one (2%) used both
multiple imputation and complete-case but did not state
which was the main method, one (2%) excluded incom-
plete covariates from the analysis model and one (2%)
removed individuals with missing data in specific covari-
ates. For the 18 studies using Schoenfeld residuals, six
(33%) used multiple imputation as the main method for
handling missing data. For the 12 studies using visual
inspection of survivor curve plots four (33%) used mul-
tiple imputation and for the 10 including an interaction
with time, three (30%) used multiple imputation as the
main method.
Five studies discovered evidence for time-varying
effects, of which three (60%) had incomplete covariates
associated with time-varying effects. Two (67%) of these
used multiple imputation to impute the missing values in
the covariate, of which one took into account the time-
varying effect using methods developed by Keogh and
Morris [5] and the other stated usingMICEwhile the third
study was unclear on how they handled the missing data.
Software
Forty-four (30%) studies used SPSS, 41 (28%) used SAS, 36
(24%) used Stata, 11 (7%) used R, two (1%) used winbugs,
one (1%) used XL-stat life and 17 (11%) did not state. Of
these, three (2%) used both SAS and SPSS, one (1%) used
SAS and Stata together, one (1%) used SAS and S-plus and
one (1%) used SAS and Mplus. Of the 11 studies using R,
four (36%) used multiple imputation with three using the
MICE package and one using Hmisc. Examples of other
potential packages that could have been used are Amelia
[20], jomo [21] or smcfcs [22].
Discussion
Missing data is a pervasive problem in observational time-
to-event studies. However, this review has found that few
studies appropriately report this issue.Whether this is due
to a lack of appreciation of the potential implications of
missing data from the researcher, or to the handling of
missing data not being deemed of high enough impor-
tance to be described in the “Methods” section is unclear.
There are general guidelines in place such as STROBE
[7, 8] and Sterne’s specific multiple imputation recom-
mendations [6] from 2007 and 2009, respectively, but it
appears that many of their recommendations are still not
being implemented. By considering literature from 2012
onwards, all papers we reviewed came after the publica-
tion of these guidelines. Over half of papers considered
(53%) were from 2016 onwards. A surprising finding was
that inmany studies it was not clear how the study popula-
tion was selected and what the extent of missing data was.
We recommend that authors provide clear and compre-
hensive information on these aspects including detailing
the finalisation of the study population, and stating the
sample size used in each model when missing data are
present. These recommendations would aid in the trans-
parency of research findings.
Methods for handling missing data such as the mul-
tiple imputation approach of White and Royston [3]
were implemented by two studies in 2014 [23] and 2016
[24], five and seven years respectively after the method
was published. Although valid methods have been devel-
oped to handle missing data, the easier-to-implement
approach of complete-case analysis is still the most pop-
ular method used. However, the studies suggest that little
or no consideration is being given to the missing data
assumptions needed for this method and whether they
are introducing bias to their results. It is plausible that
some authors had not noticed the missing data, since
software by default runs complete-case analysis with-
out flagging that some individuals were dropped from
the analysis. Also of note are the studies which have a
‘fully’ observed dataset and therefore had no need to
consider any missing data assumptions or methods. How-
ever, this ‘fully’ observed dataset originated from using
a complete-case inclusion/exclusion criteria for individ-
uals entering their study. These studies gave no con-
sideration to missing data assumptions and only seven
(16%) considered the missing data excluded to be a
limitation.
Several systematic reviews have been conducted to
assess the handling of missing data in studies, most of
which have focus on randomized trials. Wood et al. [25]
reviewed the handling of missing outcome data in ran-
domized control trials published in 2001. They found
that missing data are typically handled inadequately and
that there was almost no use of modern data meth-
ods with complete-case used in 46% of studies. Similar
findings were made in other reviews covering trials pub-
lished between 2005 and 2014 [26–28]. Karahalios et al.
[29] focused on missing data in cohort studies published
between 2000 and 2009 and found inconsistent reporting
of missing data and inappropriate methods used with 66%
of studies using complete-case analysis. With regards to
missing data, these reviews collectively looked at studies
published between 2001 and 2014. They, along with our
own review looking at papers from 2012 to 2018, highlight
the lack of progress that has been made in appropriate
handling of missing data in both trials and observational
studies.
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Our review revealed a lack of rigour in other aspects of
a study investigation. 42% of studies did not state how the
covariates were selected for their final model. When con-
ducting a covariate selection procedure, thought should
also be given to continuous covariates and whether cat-
egorising is worth a loss of power to detect associations
or the occurrence of residual confounding [30]. Clarity
should also be required for how the selection procedure
is combined when using multiple imputation. For exam-
ple, [31] states using multiple imputation for multivariable
analyses and goes on to detail that univariable models and
backward selection were used. However, no discussion is
given as to if this process was repeated across the multi-
ple imputed datasets and, if so, what happened when there
were disagreements across them regarding the selection
process? In 2008, Wood et al. [32] discusses methods to
handle covariate selection withmultiple imputation. Stud-
ies included in the review tended to be exploratory or
predictive in nature and consideration should be given to
the selection procedure for including covariates into these
models. Stepwise methods were used in 37% of studies
which stated a covariate selection procedure despite the
disadvantages being well-known [33, p. 68]. These include
underestimating standard errors of parameter estimates,
narrow confidence intervals, low p-values and parameter
estimates biased away from zero. VanderWeele also dis-
cusses the use of stepwise methods and their drawbacks
in a causal setting [34].
For the 41 studies that checked the PH assumption, it
was not clear how the 13 studies using multiple impu-
tation incorporated the use of Schoenfeld residuals or
inspection of survivor curves as these details were not
provided. For those using a time-interaction and multiple
imputation, only one did not make it clear how they were
incorporating the two methods. Using again the exam-
ple of [31] it is possible that they checked the assumption
using scaled Schoenfeld residuals over time in a complete-
case scenario or individually in each imputed dataset but
without specification it is difficult to say whether the
assumption diagnostics were carried out appropriately. It
is important to note that when considering compatibil-
ity between the analysis and imputation model thought
should also be given to allowing for time-varying effects
in the imputation process, in order to allow for valid tests
of the proportional hazards assumption. Further thought
should also be provided on whether there is sufficient
statistical power to detect violations of the proportional
hazards assumption [35].
This review demonstrates poor adherence to guidelines
already in place and further drives the need for clear
reporting. Ideally, an external analyst should be able to
rerun the study analysis from the information published
which is currently not possible in many studies. Finally,
Table 4 provides some related references for considera-
tion of different aspects of missing data and time-to-event
features in a study.
Limitations of review
A large number of search terms were used to extract the
relevant studies. However, it is possible that some time-to-
event studies did not mention how they handled missing
data in the title, abstract or keywords and therefore were
not included in the review. The search also focused solely
on oncology, it is possible that in other medical setting
studies could be performed differently in terms of report-
ing or methods used. A further limitation stems from
only one reviewer identifying, screening and extracting
information from the studies which may have introduced
bias from the selection and interpretation of papers. An
agreement check was conducted with RHK and TPM and
initially found poor agreement in the collection of sam-
ple size of studies and the amount of missing data. The
data collection check-list was reviewed and amended to
improve discrepancies.
Many journals have a page or word limit which restricts
the study analysts from fully detailing methods conducted
and results. It is possible that studies were unable to
detail information such as checking the PH assessment or
conducting a sensitivity analysis. However, most journals
also allow for online supplementary materials which could
have been used.
For this review we focused on methods used in the
oncology field. It is possible that the handling of miss-
ing data may be better or worse in other medical fields or
study designs.
Recommendations formultiple imputation in time-to-event
analyses
While it is difficult to recommend a gold standard method
as it can depend on the context of the study, for time-to-
event studies involving the Cox model we would recom-
mend using the substantive model compatible fully condi-
tional specification (SMC-FCS) of Bartlett et al. [4] as the
gold standard method for multiple imputation. It allows
for compatibility between the study analysis model and
the imputation model. This method is available in both
Stata and R software. Keogh and Morris [5] have adapted
SMC-FCS to allow for the presence of time-varying effects
and proposed an algorithm to allow for model selection
with time-varying effects.
White and Royston [3] recommend the inclusion of
the event indicator and the Nelson-Aalen estimator in
the imputation model for an approximately compatible
model. While this is simpler and more straightforward
using widely available MI software, the approximation can
perform badly in ‘extreme’ scenarios such as strong covari-
ate effects and a high event rate. The approximation also
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Table 4 Selected papers describing methods for addressing common issues arising in the analysis of time-to-event data when there is
missing covariate data
Consideration Some recommended references
Missing data (general)
General recommendations [6] Sterne et al.: Recommendations for missing data and multiple imputation
Simple imputation [36] Zhang: Mean, median, mode, regression imputations
Complete-case bias considerations [37] Bartlett et al.: When CC is valid
[38] Carpenter & Kenward: When CC is valid
Multiple imputation
Number of imputations to use [15] White et al.: at least the percentage of incomplete cases
[39] von Hippel: two-stage quadratic rule
Covariate selection procedures [32] Wood et al.: Repeated use of Rubin’s rules or stacking approach
[40] Morris et al.: Adapted for MFP including selection procedure and functional form
Non-linear effects [40] Morris et al.: Adapted for MFP including selection procedure and functional form
[41] Seaman et al.: recommend just another variable (JAV) approach
Using a Cox model [3] White & Royston: inclusion of Nelson-Aalen estimate and event indicator in imputation
model
[4] Bartlett & Seaman: full conditional specification adjusting for the analysis model of choice
Testing the Proportional hazards
assumption and modelling time-varying
effects of covariates
[5] Keogh &Morris: adapting White & Royston and Bartlett & Seaman approaches for
time-varying effects
Time-dependent covariates [42] De Silva et al.: Investigating performance of two-fold fully conditional specification for
time-dependet covariates
[43] Moreno-Betancur et al.: Use of joint modelling for time-dependent covariates
Time-to-event features not concerningmissing data
Functional form [44] Sauerbrei et al.: multivariable fractional polynomial time i.e. MFP in survival setting
accounting for time-varying effects
[45] Buchholz & Sauerbrei: comparison of procedures for assessing time-varying effects and
functional form
[46] Heinzl & Kaider: Using cubic spline functions to assess functional form
[47] Wynant & Abrahamowicz: Importance of assessing time-varying effects and functional
form
[48] Abrahamowicz &MacKenzie: Joint estimation of time-varying effects and functional form
using splines
Covariate selection procedures [44] See above
[49] Yan & Huang: Assessing time-varying effects using an adaptive lasso method
Testing the Proportional hazards assumption [35] Austin: Assessing power of tests to assess proportional hazards assumption
[50] Bellera et al.: Recommend assessing proportional hazards assumption and inclusion of
time-varying effects where necessary
[51] Abrahamowicz et al.: use of regression splines to model time-varying effects
[52] Hess: use of cubic splines to model time-varying effects
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Table 4 Selected papers describing methods for addressing common issues arising in the analysis of time-to-event data when there is
missing covariate data (Continued)






Categorising of covariates [53] MacCallum et al.: Discussion on dichotomising continuous covariates
Non-linear effects [54] Royston & Sauerbrei: Text book providing overview of model selection with a focus on
MFP procedures
[33] Harrell: Text book providing overview of strategies for regression modelling
Covariate selection procedures [54] See above
[55] Heinze et al.: Review of methods for covariate selection
MFP: Multivariable fractional polynomials
has weaker statistical properties (estimators will generally
be inconsistent) than SMC-FCS due to semi-compatibility
of the imputation and analysis model. Keogh and Morris
have also adapted White and Royston’s method to handle
time-varying effects.
Conclusions
More consideration is required for observational time-to-
event analyses with missing data, including clear report-
ing of how the missing data were handled and how any
selection procedures or assumption checks were con-
ducted in conjunction with the missing data method
implemented. Wider thought should be given to the lim-
itations the missing data introduces to the observational
study, such as bias of parameter estimates, and which
methods can be used to help deal with this. While meth-
ods such as complete-case analysis are well ingrained in
the community there are more modern methods which
should also be considered when conducting a study.
There appears to be a delay between methodology pub-
lication and uptake into the applied research field [56]
or, rather, a delay in departing from simpler favoured
methods of the field. There are many published guide-
lines readily available to help researchers conduct and
report their study and these should be consulted, along-
side a statistician. All recommendations that came from
conducting the review were found to have already been
emphasised in the published guidance discussed in the
Introduction section of this paper. Finally, we recommend
that journal editors have requirements for appropriate
reporting in the presence of missing data to ensure high
quality studies are published and that their results are
robust.
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